Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Side Effect of Drug × 30 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 327 Neoplasms 244 Prostatic Neoplasms 194 Lung Neoplasms 147 Carcinoma, Non-Small-Cell Lung 125 Leukemia, Myeloid, Acute 114 Colorectal Neoplasms 109 Brain Neoplasms 86 Neoplasm Metastasis 82 Multiple Myeloma 79 Pancreatic Neoplasms 69 Melanoma 68 Carcinoma, Hepatocellular 67 Ovarian Neoplasms 65 Glioma 63 Glioblastoma 58 Squamous Cell Carcinoma of Head and Neck 56 Precursor Cell Lymphoblastic Leukemia-Lymphoma 56 Head and Neck Neoplasms 55 Uterine Cervical Neoplasms 52 Sarcoma 52 Recurrence 49 Urinary Bladder Neoplasms 48 Colonic Neoplasms 46 Myelodysplastic Syndromes 45 Hematologic Neoplasms 45 Lymphoma 43 Triple Negative Breast Neoplasms 42 Carcinoma, Renal Cell 40 Rectal Neoplasms 39

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04701151 2026-03-03

NORTH-REG Dwell-Time Study

Aarhus University Hospital

Phase 4 Active not recruiting

Side Effect of Drug

Data powered by HemOnc (CC BY 4.0) Colophon ⚡